Clinical trial Recruiting at 4 sites Interventional Ages 6 to 16

Using virtual reality to reduce pain and anxiety during needle placements in children with leukemia

Official title: Evaluation of the Efficacy of a Virtual Reality When Placing a Needle on an Implantable Venous Access Device in Children With Leukemia: Randomized Multicenter Trial

Run by University Hospital, Clermont-Ferrand · NCT06697275 · Data updated 2026-11-12

This study tests if using virtual reality can help reduce pain and anxiety for kids with leukemia during needle placements.

Quick facts

Study typeInterventional
Ages6 Years to 16 Years
SexAll
Enrollment120 (estimated)
SponsorUniversity Hospital, Clermont-Ferrand
Academic / other
Drugs / interventionschemotherapy
Locations4 sites (Bordeaux and 3 other locations)
StatusRecruiting
StartedNovember 15, 2024
Main results expectedOctober 1, 2027
Study endsOctober 1, 2027
Registry record updatedDecember 4, 2025
Trial IDNCT06697275 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 6 to 16 diagnosed with leukemia who require needle insertion into an implantable port and have a life expectancy of at least three months.

Probably not a fit

Patients with conditions that contraindicate the use of virtual reality or those with severe neurological or psychiatric disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of using interactive or hypnotic virtual reality to manage pain and anxiety during needle placements for children and adolescents aged 6 to 16 with acute leukemia. Over a period of three months, participants will receive either virtual reality interventions or standard treatment while undergoing needle insertion into an implantable port. The study aims to assess improvements in pain management, anxiety levels, and overall satisfaction for both the children and their caregivers compared to traditional methods. The goal is to provide a non-drug intervention that enhances the care experience for these young patients.

Why it matters

Potential benefit: If successful, this approach could significantly reduce pain and anxiety for children undergoing frequent medical procedures.

How similar studies have gone: Previous studies have shown promising results using virtual reality for pain and anxiety management in pediatric populations, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children from 6 to 16 years old suffering from leukemia requiring needle insertion into an implantable port and having a life expectancy greater than or equal to 3 months
* Subjects and their parents who have been informed of the study and having expressed their informed consent
* Children without contraindications to the use of MEOPA® :
* Patient requiring 100% oxygen ventilation
* Intracranial hypertension
* Any alteration in the state of consciousness preventing the patient\'s cooperation
* Children without contraindication to the use of the virtual reality mask:
* Epilepsy
* Psychiatric illness
* Children and parents able to use the self-assessment scales proposed in the study
* Enrolment in the Social Security system

Exclusion Criteria:

Children from 6 to 16:

* Having a modification of pain\'s integration (spina bifida for example)
* Requiring contact isolation (conjunctivitis, contagious skin condition, etc.)
* With a history of seizures

Where it's running

  • CHU de Bordeaux
    Bordeaux, France
    Recruiting
  • CHU de Clermont-Ferrand
    Clermont-Ferrand, France
    Recruiting
  • Assistance Publique - Hôpitaux de Marseille
    Marseille, France
    Recruiting
  • CHU de Toulouse
    Toulouse, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.